Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders.

PubWeight™: 11.14‹?› | Rank: Top 0.1%

🔗 View Article (PMC 2082049)

Published in Nat Genet on December 17, 2006

Authors

Christelle M Durand1, Catalina Betancur, Tobias M Boeckers, Juergen Bockmann, Pauline Chaste, Fabien Fauchereau, Gudrun Nygren, Maria Rastam, I Carina Gillberg, Henrik Anckarsäter, Eili Sponheim, Hany Goubran-Botros, Richard Delorme, Nadia Chabane, Marie-Christine Mouren-Simeoni, Philippe de Mas, Eric Bieth, Bernadette Rogé, Delphine Héron, Lydie Burglen, Christopher Gillberg, Marion Leboyer, Thomas Bourgeron

Author Affiliations

1: Human Genetics and Cognitive Functions, Institut Pasteur, Paris, France.

Articles citing this

(truncated to the top 100)

Strong association of de novo copy number mutations with autism. Science (2007) 27.84

Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet (2008) 15.51

Functional impact of global rare copy number variation in autism spectrum disorders. Nature (2010) 14.66

Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet (2007) 14.05

Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet (2008) 12.18

Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature (2011) 10.16

Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature (2010) 9.81

Neuroligins and neurexins link synaptic function to cognitive disease. Nature (2008) 9.23

Identifying autism loci and genes by tracing recent shared ancestry. Science (2008) 7.72

A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science (2007) 6.64

A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay. Nat Genet (2010) 6.62

Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature (2011) 5.62

Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. Am J Hum Genet (2008) 5.44

Contribution of SHANK3 mutations to autism spectrum disorder. Am J Hum Genet (2007) 5.04

CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell (2012) 4.81

Dendritic spine pathology in neuropsychiatric disorders. Nat Neurosci (2011) 4.80

MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron (2007) 4.15

Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. Proc Natl Acad Sci U S A (2010) 4.02

Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proc Natl Acad Sci U S A (2008) 3.74

Genomics, intellectual disability, and autism. N Engl J Med (2012) 3.74

Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat Genet (2010) 3.73

Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth. Am J Hum Genet (2012) 3.50

A genome-wide scan for common alleles affecting risk for autism. Hum Mol Genet (2010) 3.42

De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc Natl Acad Sci U S A (2010) 3.13

Interneuron dysfunction in psychiatric disorders. Nat Rev Neurosci (2012) 2.87

Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability. Am J Hum Genet (2011) 2.86

Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch Gen Psychiatry (2009) 2.82

Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genet (2012) 2.65

AutDB: a gene reference resource for autism research. Nucleic Acids Res (2008) 2.62

The conundrums of understanding genetic risks for autism spectrum disorders. Nat Neurosci (2011) 2.61

Neuroligin-1 deletion results in impaired spatial memory and increased repetitive behavior. J Neurosci (2010) 2.57

Heterogeneous dysregulation of microRNAs across the autism spectrum. Neurogenetics (2008) 2.50

Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication. Mol Autism (2010) 2.47

Individual common variants exert weak effects on the risk for autism spectrum disorderspi. Hum Mol Genet (2012) 2.46

Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities. Cold Spring Harb Perspect Biol (2012) 2.42

CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila. Am J Hum Genet (2009) 2.41

Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Hum Mol Genet (2011) 2.38

Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. Nature (2012) 2.36

Smaller dendritic spines, weaker synaptic transmission, but enhanced spatial learning in mice lacking Shank1. J Neurosci (2008) 2.27

Neuronal activity-regulated gene transcription in synapse development and cognitive function. Cold Spring Harb Perspect Biol (2011) 2.27

A de novo convergence of autism genetics and molecular neuroscience. Trends Neurosci (2013) 2.24

Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders. Am J Med Genet B Neuropsychiatr Genet (2010) 2.12

Characterizing brain cortical plasticity and network dynamics across the age-span in health and disease with TMS-EEG and TMS-fMRI. Brain Topogr (2011) 2.12

Minimal aberrant behavioral phenotypes of neuroligin-3 R451C knockin mice. Autism Res (2008) 2.08

Protein interactome reveals converging molecular pathways among autism disorders. Sci Transl Med (2011) 2.04

Autism and brain development. Cell (2008) 2.01

The 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome). Mol Syndromol (2011) 1.94

SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients. Nature (2013) 1.93

The intense world theory - a unifying theory of the neurobiology of autism. Front Hum Neurosci (2010) 1.91

Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci. Neuron (2015) 1.91

SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties. Nature (2013) 1.86

SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism. Mol Psychiatry (2011) 1.79

Abnormal melatonin synthesis in autism spectrum disorders. Mol Psychiatry (2007) 1.79

Deletion 22q13.3 syndrome. Orphanet J Rare Dis (2008) 1.77

Disruption at the PTCHD1 Locus on Xp22.11 in Autism spectrum disorder and intellectual disability. Sci Transl Med (2010) 1.75

Reduced excitatory neurotransmission and mild autism-relevant phenotypes in adolescent Shank3 null mutant mice. J Neurosci (2012) 1.71

Subsynaptic AMPA receptor distribution is acutely regulated by actin-driven reorganization of the postsynaptic density. J Neurosci (2012) 1.71

Genetic advances in autism: heterogeneity and convergence on shared pathways. Curr Opin Genet Dev (2009) 1.71

A genome-wide study of common SNPs and CNVs in cognitive performance in the CANTAB. Hum Mol Genet (2009) 1.71

Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders. Hum Mol Genet (2011) 1.70

Autism genetics: searching for specificity and convergence. Genome Biol (2012) 1.70

Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia. Mol Psychiatry (2010) 1.69

Mechanisms of synapse and dendrite maintenance and their disruption in psychiatric and neurodegenerative disorders. Annu Rev Neurosci (2010) 1.68

Modeling autism by SHANK gene mutations in mice. Neuron (2013) 1.64

Autism-linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function. Proc Natl Acad Sci U S A (2011) 1.63

Gene hunting in autism spectrum disorder: on the path to precision medicine. Lancet Neurol (2015) 1.62

Retracted Enhanced polyubiquitination of Shank3 and NMDA receptor in a mouse model of autism. Cell (2011) 1.62

Sociability and motor functions in Shank1 mutant mice. Brain Res (2010) 1.60

Molecular mechanisms generating and stabilizing terminal 22q13 deletions in 44 subjects with Phelan/McDermid syndrome. PLoS Genet (2011) 1.60

SHANK1 Deletions in Males with Autism Spectrum Disorder. Am J Hum Genet (2012) 1.59

A neuroligin-4 missense mutation associated with autism impairs neuroligin-4 folding and endoplasmic reticulum export. J Neurosci (2009) 1.59

Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: a gradient of severity in cognitive impairments. PLoS Genet (2014) 1.57

The genetics of child psychiatric disorders: focus on autism and Tourette syndrome. Neuron (2010) 1.57

Rare deletions at the neurexin 3 locus in autism spectrum disorder. Am J Hum Genet (2011) 1.56

Alterations of GABAergic signaling in autism spectrum disorders. Neural Plast (2011) 1.56

A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome. Mol Autism (2014) 1.54

The postsynaptic organization of synapses. Cold Spring Harb Perspect Biol (2011) 1.53

Gene expression in cortical interneuron precursors is prescient of their mature function. Cereb Cortex (2008) 1.51

Common DNA methylation alterations in multiple brain regions in autism. Mol Psychiatry (2013) 1.51

Increased anxiety-like behavior in mice lacking the inhibitory synapse cell adhesion molecule neuroligin 2. Genes Brain Behav (2008) 1.51

22q13.3 deletion syndrome: clinical and molecular analysis using array CGH. Am J Med Genet A (2010) 1.49

Neuroligin-1-dependent competition regulates cortical synaptogenesis and synapse number. Nat Neurosci (2012) 1.46

Risk factors for autism: translating genomic discoveries into diagnostics. Hum Genet (2011) 1.46

Autism: a "critical period" disorder? Neural Plast (2011) 1.46

High-density SNP association study and copy number variation analysis of the AUTS1 and AUTS5 loci implicate the IMMP2L-DOCK4 gene region in autism susceptibility. Mol Psychiatry (2009) 1.45

Advancing the understanding of autism disease mechanisms through genetics. Nat Med (2016) 1.45

The genetic basis of non-syndromic intellectual disability: a review. J Neurodev Disord (2010) 1.45

From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nat Rev Neurosci (2015) 1.44

Do common variants play a role in risk for autism? Evidence and theoretical musings. Brain Res (2010) 1.44

Concerted action of zinc and ProSAP/Shank in synaptogenesis and synapse maturation. EMBO J (2011) 1.44

A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder. Hum Genet (2011) 1.43

SHANK3 Deficiency Impairs Heat Hyperalgesia and TRPV1 Signaling in Primary Sensory Neurons. Neuron (2016) 1.41

Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines. Genome Med (2010) 1.41

Importance of Shank3 protein in regulating metabotropic glutamate receptor 5 (mGluR5) expression and signaling at synapses. J Biol Chem (2011) 1.40

Communication impairments in mice lacking Shank1: reduced levels of ultrasonic vocalizations and scent marking behavior. PLoS One (2011) 1.40

Gene expression profiling of lymphoblasts from autistic and nonaffected sib pairs: altered pathways in neuronal development and steroid biosynthesis. PLoS One (2009) 1.39

Multiple rare variants in the etiology of autism spectrum disorders. Dialogues Clin Neurosci (2009) 1.39

Phenotypic overlap in the contribution of individual genes to CNV pathogenicity revealed by cross-species computational analysis of single-gene mutations in humans, mice and zebrafish. Dis Model Mech (2012) 1.39

Identification of small exonic CNV from whole-exome sequence data and application to autism spectrum disorder. Am J Hum Genet (2013) 1.39

Functional significance of rare neuroligin 1 variants found in autism. PLoS Genet (2017) 1.38

Articles cited by this

Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet (2003) 15.31

A forkhead-domain gene is mutated in a severe speech and language disorder. Nature (2001) 9.25

Genetics of autism: complex aetiology for a heterogeneous disorder. Nat Rev Genet (2001) 5.91

Identification of novel autism candidate regions through analysis of reported cytogenetic abnormalities associated with autism. Mol Psychiatry (2006) 5.63

Severe expressive-language delay related to duplication of the Williams-Beuren locus. N Engl J Med (2005) 5.37

Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin. Neuron (1999) 4.59

Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci (2006) 4.22

Terminal 22q deletion syndrome: a newly recognized cause of speech and language disability in the autism spectrum. Pediatrics (2004) 3.48

Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome. Am J Hum Genet (2001) 3.09

Shank expression is sufficient to induce functional dendritic spine synapses in aspiny neurons. J Neurosci (2005) 2.96

An architectural framework that may lie at the core of the postsynaptic density. Science (2006) 2.91

Spine architecture and synaptic plasticity. Trends Neurosci (2005) 2.79

ProSAP/Shank proteins - a family of higher order organizing molecules of the postsynaptic density with an emerging role in human neurological disease. J Neurochem (2002) 2.71

Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13.3 deletion syndrome. J Med Genet (2005) 2.54

The complexity of PDZ domain-mediated interactions at glutamatergic synapses: a case study on neuroligin. Neuropharmacology (2004) 2.13

Articles by these authors

Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet (2003) 15.31

Functional impact of global rare copy number variation in autism spectrum disorders. Nature (2010) 14.66

Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet (2007) 14.05

Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature (2012) 13.71

Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02

The worldwide prevalence of ADHD: is it an American condition? World Psychiatry (2003) 5.30

The genetics of autism spectrum disorders and related neuropsychiatric disorders in childhood. Am J Psychiatry (2010) 4.92

Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res (2007) 4.47

Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. Proc Natl Acad Sci U S A (2010) 4.02

Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA. Am J Hum Genet (2012) 3.80

Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proc Natl Acad Sci U S A (2008) 3.74

A genome-wide scan for common alleles affecting risk for autism. Hum Mol Genet (2010) 3.42

Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase. Hum Mutat (2009) 2.93

An architectural framework that may lie at the core of the postsynaptic density. Science (2006) 2.91

Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet (2011) 2.71

Fragile X syndrome and autism at the intersection of genetic and neural networks. Nat Neurosci (2006) 2.68

Common genetic variants, acting additively, are a major source of risk for autism. Mol Autism (2012) 2.67

Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genet (2012) 2.65

Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome. Nat Genet (2005) 2.64

Autism after adolescence: population-based 13- to 22-year follow-up study of 120 individuals with autism diagnosed in childhood. J Autism Dev Disord (2005) 2.59

European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry (2010) 2.53

Mutations at a single codon in Mad homology 2 domain of SMAD4 cause Myhre syndrome. Nat Genet (2011) 2.52

Individual common variants exert weak effects on the risk for autism spectrum disorderspi. Hum Mol Genet (2012) 2.46

β-Propeller protein-associated neurodegeneration: a new X-linked dominant disorder with brain iron accumulation. Brain (2013) 2.40

Ketamine administration in depressive disorders: a systematic review and meta-analysis. Psychopharmacology (Berl) (2014) 2.37

Impaired decision making in suicide attempters. Am J Psychiatry (2005) 2.37

Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. Nature (2012) 2.36

Functional inactivation of a fraction of excitatory synapses in mice deficient for the active zone protein bassoon. Neuron (2003) 2.31

ARX, a novel Prd-class-homeobox gene highly expressed in the telencephalon, is mutated in X-linked mental retardation. Hum Mol Genet (2002) 2.30

Excess of high frequency electroencephalogram oscillations in boys with autism. Biol Psychiatry (2007) 2.15

Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends Genet (2010) 2.14

Abnormal cortical voice processing in autism. Nat Neurosci (2004) 2.11

High NPHP1 and NPHP6 mutation rate in patients with Joubert syndrome and nephronophthisis: potential epistatic effect of NPHP6 and AHI1 mutations in patients with NPHP1 mutations. J Am Soc Nephrol (2007) 2.06

Autism spectrum disorders in children with active epilepsy and learning disability: comorbidity, pre- and perinatal background, and seizure characteristics. Dev Med Child Neurol (2003) 2.06

Psychiatric and psychosocial problems in adults with normal-intelligence autism spectrum disorders. BMC Psychiatry (2009) 2.03

Adolescent-onset anorexia nervosa: 18-year outcome. Br J Psychiatry (2009) 2.03

Specific genetic disorders and autism: clinical contribution towards their identification. J Autism Dev Disord (2005) 2.03

Examining and interpreting the female protective effect against autistic behavior. Proc Natl Acad Sci U S A (2013) 1.99

[Children and young people with neurodevelopmental problems: Support and efforts must be given even if not all diagnostic criteria are met]. Lakartidningen (2013) 1.95

Psychiatric disorders in Norwegian 8- to 10-year-olds: an epidemiological survey of prevalence, risk factors, and service use. J Am Acad Child Adolesc Psychiatry (2007) 1.90

Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome. J Med Genet (2007) 1.89

Variation in the oxytocin receptor gene is associated with pair-bonding and social behavior. Biol Psychiatry (2011) 1.89

Longitudinal studies of cognition in schizophrenia: meta-analysis. Br J Psychiatry (2008) 1.89

Co-existing disorders in ADHD -- implications for diagnosis and intervention. Eur Child Adolesc Psychiatry (2004) 1.88

Autism spectrum disorders in children with normal intellectual levels: associated impairments and subgroups. Dev Med Child Neurol (2004) 1.87

Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid. Int J Alzheimers Dis (2010) 1.86

Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculo-acoustico-renal syndromes. Nat Genet (2007) 1.85

A common X-linked inborn error of carnitine biosynthesis may be a risk factor for nondysmorphic autism. Proc Natl Acad Sci U S A (2012) 1.85